Read + Share
Ramalingam SS, Thara E, Awad MM, Dowlati A, et al. JASPER: Phase 2 trial of first-line niraparib plus pembrolizumab in patients with
advanced non-small cell lung cancer. Cancer 2021 Sep 3. doi: 10.1002/cncr.33885.
PMID: 34478166
|
 |
|
Ramalingam SS, Thara E, Awad MM, Dowlati A, et al. JASPER: Phase 2 trial of first-line niraparib plus pembrolizumab in patients with
advanced non-small cell lung cancer. Cancer 2021 Sep 3. doi: 10.1002/cncr.33885.
PMID: 34478166
|
|
|
|